Back
Incyte 10K Form
Sell
46
INCY
Incyte
Last Price:
$69.24
Seasonality Move:
1.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-30 | 10Q | INCY/Incyte Quarterly |
| 2023-10-31 | 10Q | INCY/Incyte Quarterly |
| 2023-08-01 | 10Q | INCY/Incyte Quarterly |
| 2023-05-02 | 10Q | INCY/Incyte Quarterly |
| 2022-11-01 | 10Q | INCY/Incyte Quarterly |
| 2022-08-02 | 10Q | INCY/Incyte Quarterly |
Receive INCY News And Ratings
See the #1 stock for the next 7 days that we like better than INCY
INCY Financial Statistics
Sales & Book Value
| Annual Sales: | $4.2B |
|---|---|
| Cash Flow: | $262.9M |
| Price / Cash Flow: | 48.39 |
| Annual Sales: | $18.93 |
| Price / Book: | 3.6 |
Profitability
| EPS (TTM): | 0.32000 |
|---|---|
| Net Income (TTM): | $21.3M |
| Gross Margin: | $3.9B |
| Return on Equity: | 0.57% |
| Return on Assets: | 0.38% |
Incyte Earnings Forecast
Key Incyte Financial Ratios
-
The Gross Profit Margin over the past 32 years for INCY is 92.64%.
-
The Selling, General & Administrative Expenses for INCY have been equal to 28.81% of Gross Profit Margin.
-
The Research & Development expenses have been 61.46% of Revenue.
-
The Interest Expense is 6.99% of Operating Income.
-
The Net Earning history of INCY is 0.77% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 18 years.
Incyte Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INCY |
| CUSIP: | 45337C |
| Website: | incyte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.04 |
| Quick Ratio: | 1.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 455 |
|---|---|
| Forward P/E Ratio: | 10.14 |